Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.3%

5 terminated out of 60 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

10%

6 trials in Phase 3/4

Results Transparency

25%

5 of 20 completed with results

Key Signals

5 with results80% success

Data Visualizations

Phase Distribution

32Total
Not Applicable (8)
Early P 1 (1)
P 1 (5)
P 2 (12)
P 3 (1)
P 4 (5)

Trial Status

Completed20
Recruiting15
Unknown10
Not Yet Recruiting5
Terminated5
Active Not Recruiting3

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (60)

Showing 20 of 20 trials
NCT06381453Phase 2RecruitingPrimary

Belimumab in Autoimmune Hepatitis

NCT06519162RecruitingPrimary

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

NCT03217422Phase 2CompletedPrimary

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

NCT07378202Active Not RecruitingPrimary

Machine Learning for Prediction of Therapy Response in Autoimmune Hepatitis

NCT05569759Phase 2CompletedPrimary

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

NCT05740358Active Not Recruiting

Liver Cirrhosis Network Cohort Study

NCT03743272Completed

Repeatability and Reproducibility of Multiparametric MRI

NCT06455280Phase 1Recruiting

A Study of SIPLIZUMAB in AILD and LT Patients

NCT04902807Recruiting

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT06061341Enrolling By Invitation

TruGraf Liver Gene Expression Serial Test

NCT03146884Recruiting

Swiss Autoimmune Hepatitis Cohort Study

NCT07118657Not ApplicableNot Yet RecruitingPrimary

Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis.

NCT05750498RecruitingPrimary

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

NCT06250309Not ApplicableRecruitingPrimary

Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients

NCT06896383Not Yet RecruitingPrimary

Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis

NCT05476900Phase 2CompletedPrimary

A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

NCT06855667Not ApplicableNot Yet RecruitingPrimary

Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.

NCT06761209RecruitingPrimary

Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?

NCT03178630Recruiting

MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease

NCT03175471Recruiting

MRI Based Biomarkers in Pediatric Autoimmune Liver Disease

Scroll to load more

Research Network

Activity Timeline